A Refreshing Outlook - Consensus Reports on Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.
(firmenpresse) - JAKARTA, INDONESIA -- (Marketwire) -- 10/19/12 -- Moments ago, introduced new coverage of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) and Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA). Full outlook, analysis and consensus opinion is available to readers via the links below.
The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include the spark of U.S. housing starts soaring past expectations to a four-year high in September, industrial production rising 0.4% in September 2012 beating expectations for a 0.2% increase and the recent upward surprise in initial jobless claims bouncing upward to 388,000 above expectations of 365,000 in the latest week. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.
Investors Alliance is releasing new coverage on Keryx Biopharmaceuticals, Inc. for its current position within the consumer durables sector. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. A copy of this report featuring Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) is available at: .
Investors Alliance has released research on Momenta Pharmaceuticals, Inc. for its changing role within the health care sector. Momenta Pharmaceuticals, Inc. (Momenta) is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). To access the full research report on Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) we welcome investors to visit: .
What is Investors Alliance?
Imagine a community wherein investors and traders of all walks share both knowledge and experience... enabling a knowledge base vastly greater than the sum of its parts. By joining forces, the entire community experiences the wealth of information, insight and intuition into some of the best strategies available today.
Patricia Byers
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.10.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1161889
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
JAKARTA, INDONESIA
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 148 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"A Refreshing Outlook - Consensus Reports on Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Investors Alliance (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
